Clinical trial Recruiting at 1 site Observational

Registry for Endovascular Treatment of Acute Ischemic Stroke

Official title: Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study (OCIN-AIS-EVT REGISTRY)

Run by Changhai Hospital · NCT05864638 · Data updated 2026-11-12

This study is trying to see how safe and effective a specific treatment for stroke is in helping patients recover after a blocked blood vessel.

More Acute Ischemic Stroke trials

Quick facts

Study typeObservational
SexAll
Enrollment10000 (estimated)
SponsorChanghai Hospital
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedMay 10, 2023
Main results expectedAugust 30, 2028
Study endsAugust 31, 2028
Registry record updatedJanuary 27, 2025
Trial IDNCT05864638 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals experiencing acute ischemic stroke due to vessel occlusion in either the anterior or posterior circulation.

Probably not a fit

Patients who do not have acute ischemic stroke or those who are not eligible for intravascular therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The OCIN-AIS-EVT REGISTRY is a prospective, multicenter observational trial designed to evaluate the safety and functional outcomes of endovascular treatment for acute ischemic stroke caused by vessel occlusion. This study will assess patients undergoing intravascular therapy and will measure outcomes using the modified Rankin scale at 90 days post-treatment. By collecting data from multiple centers, the registry aims to reflect routine clinical practice and provide insights into the effectiveness of these interventions.

Why it matters

Potential benefit: If successful, this study could improve treatment protocols and outcomes for patients suffering from acute ischemic stroke.

How similar studies have gone: Other studies have shown promising results with endovascular treatments for acute ischemic stroke, indicating a potential for success in this registry approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Acute ischemic stroke caused by anterior or posterior circulation vessel occlusion confirmed by computed tomography angiography (CTA) or magnetic resonance angiography (MRA) or digital subtraction angiography (DSA)
2. Undergo intravascular therapy (i.e. access to a cath lab and an arterial puncture)
3. The patient or his/her legal representative agreed to participate in the study and has signed the informed consent.

Exclusion Criteria:

1\) No exclusion criteria

Where it's running

  • Jianimin Liu
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.